Country for PR: China
Contributor: Xinhua News Agency
Tuesday, August 30 2022 - 19:36
AsiaNet
Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area
NANNING, China, Aug. 30, 2022 /Xinhua-AsiaNet/--

Recently, the lung CT image-aided diagnosis software developed by Guangxi 
Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic 
& Technological Development Area ("Area") has been granted the registration 
certificate of class III medical devices (GXZZ20223210687).

Nanning's investment promotion departments at all levels aim at creating 
biomedical industry clusters through high starting point planning and 
attraction of targeted investments, according to National Nanning Economic & 
Technological Development Area Management Committee. In the Area, the 
biomedical industry, involving the fields of production, inspection & testing, 
sales and distribution, continually expands in industrial scale and gradually 
improves in industrial chain. The approved "lung CT image-aided diagnosis 
software" is the first software in Guangxi province and the country's eighth 
one with the registration certificate of class III AI medical devices and 
software, and the sixth in Guangxi province and the second in Nanning city to 
have received the certificate. This is another achievement of the city's 
continuous optimization of services for moved-in enterprises and solid efforts 
in building up the biopharmaceutical industry.

In terms of precise investments, the Area has compiled a panorama of 
biopharmaceutical industry chain, positively brought in investments in the 
industry chain and industry clusters and introduced a batch of key projects 
such as Hainan Huluwa Pharmaceutical, Guangdong Yili Pharmaceutical, Yida 
Xiansheng, Sinopharm Group and Guangxi LiuYao Group, forming an industrial 
development pattern with biopharmaceuticals, traditional Chinese medicine, 
health care products, medical devices and modern pharmaceutical logistics as 
main fields. According to information, the Area is the major ground to develop 
the biopharmaceutical industry in the city, and there are currently 625 
biopharmaceutical enterprises in the Area.

Source: National Nanning Economic & Technological Development Area Management 
Committee

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=428269

   Caption: Production workshop of Nanning Neptunus Health Industrial Park